## Abstract There are increasing reports showing the clinical significance of the __p53__ polymorphism status in terms of the response to chemotherapy. We investigated whether __p53__ polymorphism and mutation were associated with __in vitro__ sensitivity to 5‐fluorouracil (5‐FU) in patients with c
p53mutations and codon 213 polymorphism ofp53in lung cancers of former uranium miners
✍ Scribed by Walter Popp; Carola Vahrenholz; Hans Schuster; Bernhard Wiesner; Peter Bauer; Frank Täuscher; Helmut Plogmann; Konrad Morgenroth; Nikolaus Konietzko; Klaus Norpoth
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 91 KB
- Volume
- 125
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background The oncogene product EGF-receptor (EGF-R), the tumor suppressor gene product p53, and anti-p53 antibodies are detectable in serum of certain cancer patients. Increased levels of some of these products were reported in lung cancer patients after occupational asbestos exposure, after exposu
We investigated if the presence of single nucleotide polymorphisms (SNPs) in the XRCC1, XRCC3, and XPD genes were associated with the type and frequency of p53 mutations in bladder cancer. Using a hospital-based case-control study we have previously reported risks for the XRCC1 codon 194, XRCC1 codo
## Abstract The p53 gene is involved in the control of cell‐cycle arrest and apoptosis. The germline Arg72Pro polymorphism alters the protein's biochemical functions, and may confer individual susceptibility to skin cancer. We evaluated the association of the Arg72Pro polymorphism with skin cancer